Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview

ISSN: 1875-6212 (Online)
ISSN: 1570-1611 (Print)

Volume 13, 6 Issues, 2015

Download PDF Flyer

Current Vascular Pharmacology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 23rd of 60 in Peripheral Vascular Disease
  • 84th of 254 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Dimitri P. Mikhailidis
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street
London, NW3 2QG

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.966
5 - Year: 2.960

Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview

Current Vascular Pharmacology, 12(4): 627-641.

Author(s): Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis and Dimitri P Mikhailidis.

Affiliation: Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece, 44, Tsimiski Street, Thessaloniki, 54623, Greece.


Metabolic syndrome (MetS), a cluster of dyslipidaemia, central obesity, hypertension and/or insulin resistance, is associated with increased cardiovascular disease (CVD) type 2 diabetes risk. Different diagnostic criteria for MetS have been proposed but in 2009 a joint statement by several scientific societies was released.

Apart from the diagnostic criteria, MetS has also been associated with other risk factors including waist to hip ratio, high density lipoprotein dysfunction, small dense low density lipoprotein, postprandial hypertriglyceridaemia, lipoprotein (a), uric acid, liver function tests, prothrombotic factors, cytokines, adipokines, vitamin D, arterial stiffness, renal dysfunction, nephrolithiasis, polycystic ovary syndrome, obstructive sleep apnea.

We discuss the extensive list of MetS-associated factors that may influence vascular risk. Furthermore, we discuss the impact of frequently prescribed drugs (e.g. hypolipidaemic agents) on these variables. These effects may need to be taken into consideration when treating MetS patients.


Arterial stiffness, cytokines, diagnostic criteria, lipids, metabolic syndrome, platelets, renal dysfunction, uric acid.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 12
Issue Number: 4
First Page: 627
Last Page: 641
Page Count: 15
DOI: 10.2174/15701611113119990131

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science